China Dasheng Biotechnology Co - Current report filing (8-K)
07 August 2008 - 11:15PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
___________
FORM
8-K
___________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): August 4, 2008
Commission
File Number: 333- 141327
CHINA DASHENG BIOTECHNOLOGY
COMPANY
(Exact
name of small business issuer as specified in its charter)
|
|
|
|
|
Nevada
|
|
26-0162321
|
|
(State
or other jurisdiction of incorporation or organization)
|
|
(IRS
Employer Identification No.)
|
|
|
|
China
Dasheng Biotechnology Company
c/o
American Union Securities
100
Wall St. 15
th
Floor
New
York, NY 10005
|
|
(Address
of principal executive offices) (Zip
Code)
|
|
|
|
212-232-0120
|
|
(Issuer's
telephone number, including area
code)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General Instruction A.2. below):
|
[
]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
[
]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
[
]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
[
]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Section
4. Matters Related to Accountants and Financial Statements
Item 4.01 Changes in Registrant’s
Certifying Accountant
.
1. Previous
Independent Registered Public Accounting Firm.
A. On
August 4, 2008, China Dasheng Biotechnology Company, formerly named Max
Nutrition, Inc. (“Registrant”) dismissed its independent registered public
accounting firm, Li & Company, PC (“Li”).
B. The
reports of Li on the financial statements of the Registrant as of October
31, 2007 and for the fiscal year ended October 31, 2007 did not contain an
adverse opinion or disclaimer of opinion and were not qualified or modified as
to uncertainty, audit scope or accounting principles other than an explanatory
paragraph as to a going concern.
C.
The decision to change the independent registered public accounting firm was
recommended and approved by the sole member of the Board of the
Registrant.
D. During
the Registrant’s most recent fiscal year and the subsequent periods through
August 4, 2008, there were no disagreements with Li on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope or
procedure, which disagreements, if not resolved to the satisfaction of Li, would
have caused it to make reference thereto in its reports on the financial
statements for such years. None of the reportable events described under Item
304(a)(1)(iv) and (v), respectively, of Regulation S-K occurred within the
period from January 29, 2008 through August 4, 2008, the date of Li’s
dismissal.
E. The
Registrant provided Li with a copy of this Current Report and has requested that
it furnish the Registrant with a letter addressed to the Securities &
Exchange Commission stating whether it agrees with the above statements. A copy
of such letter is filed as Exhibit 16.1 to this Current Report on Form
8-K.
2. New Independent
Registered Public Accounting Firm.
The
Registrant, acting through its Board of Directors, has engaged Malone &
Bailey, PC as its new independent registered public accounting firm to audit and
review the Registrant’s financial statements effective June 30, 2008. Prior to
such engagement, the Registrant did not consult such firm on any of the matters
referenced in Regulation S-K Item 304(a)(2).
Section
9. Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
(a) Financial
Statements of Businesses Acquired: None
(b) Pro-Forma
Financial Statements: None
|
Exhibit
No.
|
|
Description
|
|
16.1
|
|
Letter
of Li & Company dated August 7, 2008 to the Securities and Exchange
Commission
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Max
Nutrition, Inc. (Registrant)
Date:
August 7, 2008
By:
/s/ JinJun
Qi
JinJun Qi
Chairman and CEO
China Dasheng Biotechnol... (PK) (USOTC:CDBT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
China Dasheng Biotechnol... (PK) (USOTC:CDBT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
